Changes in Liver and Splenic Stiffness after Direct-Acting Antiviral Therapy in Chronic Hepatitis C: A Single-Centre, Prospective, Observational Study

Figure 3

Changes in liver stiffness measurements (LSM) stratified by an LSM value of 1.43 m/s in patients with chronic hepatitis C treated with direct acting antivirals. (a) LSM <1.43 m/s (n =69). (b) LSM ≥1.43 m/s (n =60). Bars indicate Bonferroni-corrected p-values <0.05. Abbreviations: LSM, liver stiffness measurement; PRE, pre-treatment; EOT, end of treatment; SVR48, 48 weeks after EOT; SVR96, 96 weeks after EOT.

(a)

(b)